[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-cytokinetics-nasdaqcytk-evp-fa33019ae674-c826-7d9e-9016-863b449cf480":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"cytokinetics-nasdaqcytk-evp-fa33019ae674-c826-7d9e-9016-863b449cf480","1764802150000","Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,200 Shares","Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 2,200 shares of the firm's stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $63.89, for a total value of $140,558.00. Following the completion of the transaction, the executive vice president owned 140,610 shares of the company's stock, valued at approximately $8,983,572.90. This represents a 1.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.","https://www.marketbeat.com/instant-alerts/cytokinetics-nasdaqcytk-evp-fady-ibraham-malik-sells-2200-shares-2025-12-02/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","1"]